NASDAQ:BEAM - Nasdaq - US07373V1052 - Common Stock - Currency: USD
Taking everything into account, BEAM scores 3 out of 10 in our fundamental rating. BEAM was compared to 556 industry peers in the Biotechnology industry. BEAM has a great financial health rating, but its profitability evaluates not so good. BEAM is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -26.41% | ||
ROE | -34.49% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 2.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 8.81 | ||
Quick Ratio | 8.81 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
21.72
+0.77 (+3.68%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 34.35 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.94 | ||
P/tB | 1.94 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -26.41% | ||
ROE | -34.49% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 43.47% | ||
Cap/Sales | 15.06% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 8.81 | ||
Quick Ratio | 8.81 | ||
Altman-Z | 2.19 |